Trials / Conditions / Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
3 registered clinical trials studyying Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or M NCT03816332 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial NCT03712605 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma NCT03304639 | National Cancer Institute (NCI) | Phase 2 |